Show simple item record

dc.contributor.author Zarura, Shafea
dc.date.accessioned 2020-07-13T12:58:07Z
dc.date.available 2020-07-13T12:58:07Z
dc.date.issued 2018
dc.identifier.citation ZARURA, Shafea. Contemporary management of obesity. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 279. en_US
dc.identifier.uri https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/11289
dc.description Department of Pharmacology and Clinical Pharmacy, Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova en_US
dc.description.abstract Introduction. Obesity has become a serious public health problem in most industrialized countries, affecting a growing segment of the population. Aim of the study. Study of etiopathogenetic factors, consequences and strategies of obesity treatment in Moldova and Israel. Materials and methods. 220 patients overweight were evaluated in 2017 aged 40-79. I used the questionnaire to investigate clinical cases. Results. Our group is made up of 30% male subjects and the vast majority of 70% of female subjects. 76% of the subjects in the control group claim 3-5 meals per day, 13% consume 2-3 meals / day and only 14% - between 5-7 meals / dayIt is noticed that 55% of patients have a sedentary activity at work 40% of people were diagnosed but dyslipidemia, 20% with diabetes, 15% with hypertension, and 25% with associated diseases. It was found that 37% of patients were treated with Orlistat and 19% with Lorcaserin, of which 49% of patients treated with Orlistat and 40% of patients treated with Lorcaserin lost ≥ 10% of baseline body weight after 6 months of treatment, the mean weight difference between these preparations being 3.2 kg. Conclusions. Obesity is associated with numerous complications, such as dyslipidemia, diabetes, hypertension, etc. After 6 months of treatment, the mean difference in weight loss of Orlistat and Lorcaserin was 3.2 kg. en_US
dc.language.iso en en_US
dc.publisher MedEspera en_US
dc.subject obesity en_US
dc.subject Orlistat en_US
dc.subject Lorcaserina en_US
dc.title Contemporary management of obesity en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

  • MedEspera 2018
    The 7th International Medical Congress for Students and Young Doctors, May 3-5, 2018

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics